Non-Invasive Serum and Elastography-Based Markers of Fibrosis Staging in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review. AGDD 2024, 7 (1), 32-6. https://doi.org/10.5281/zenodo.22179529.